Main > A1. CORP. INDEX. In-Iz > Irras./P C2



Irras./P C2's subsections
2018. 07.16. USA>FDA Clearance
2019. 01.10. 1st Patient in USA
2019. 05.07. Neurocritical Care
2019. 06.25. Israel and Costa Rica
2019. 08.01. USA Patents
2019. 11.21. USA>FDA Clearance
2019. 12.16. Neurocritical Care
2019. 12.19. Renewed CE Mark
2020. 08.25. USA Patent
2022. 12.12. US FDA 510(k) Clearanc
web-site

Irras./P C2's products
This section has no products